RPS3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-29734
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry, Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for RPS3 Antibody
Immunogen
Between 193 and 243
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for RPS3 Antibody
Immunohistochemistry;RPS3 Antibody[NBP3-29733]
Immunohistochemistry;RPS3 Antibody[NBP3-29733]Detection of human RPS3 by immunohistochemistry. Samples: FFPE serial sections of human ovarian carcinoma. Antibody: Affinity purified rabbit anti-RPS3 used at a dilution of 1:1,000 . Detection: DABApplications for RPS3 Antibody
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
Tris-citrate/phosphate buffer, pH 7 to 8
Preservative
0.09% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: RPS3
Alternate Names
40S ribosomal protein S3, FLJ26283, FLJ27450, IMR-90 ribosomal protein S3, MGC87870, ribosomal protein S3
Gene Symbol
RPS3
Additional RPS3 Products
Product Specific Notices for RPS3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...